Clinical Trials Logo
  1. Home
  2. Cigarette Smoking
  3. NCT02103829
  4. Details
NCT02103829 Clinical Trial

"Quit Smoking on Your Own" Brief Online Study

Cigarette Smoking Clinical Trial

— TC-PAU-1  

Official title:
"Quit Smoking on Your Own" Brief Online Study

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT02103829
Other study ID # TC-PAU-1
Secondary ID
Status Terminated
Phase N/A
First received April 1, 2014
Last updated September 27, 2016
Start date March 2014
Est. completion date September 2016

Study information
Verified date September 2016
Source i4Health
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Most individuals who smoke want to quit smoking. Most individuals who want to quit, quit on their own. The purpose of this study is to determine whether very brief suggestions provided online are comparatively more effective than others in increasing motivation to quit immediately after the suggestions are implemented and actual quit rates one month later.

There are no costs associated with participating in this study and participants will not be compensated for their participation.

To join the study paste the following link into your browser:

https://www.i4health-pau.org/quit-smoking-on-your-own

The entire study takes place online on an automated website.

Description:

Participants will be recruited online using search engine ads (e.g., Google), online association list serves, community websites designed to reach individuals interested in participating in research studies, and social media sites related to smoking cessation efforts.

The entire study will be administered online. Participants may complete it at a time and place of their convenience.

To join the study paste the following link into your browser:

https://www.i4health-pau.org/quit-smoking-on-your-own

The website will automatically obtain consent, ask 16 brief questions as a pre-test, randomize to 4 very brief interventions, ask 4 post-test questions, and at 1-month follow-up, send an email with a link to a 6-question survey. The initial online session is expected to take between 3 and 8 minutes and the 1-month follow-up survey less than 2 minutes.

Recruitment information / eligibility
Status Terminated
Enrollment 345
Est. completion date September 2016
Est. primary completion date February 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult (18 years of age or older)

- Smoker who wants to quit

- Access to the Internet

Exclusion Criteria:

- Less than 18 years of age

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label

Related Conditions & MeSH terms

Intervention

Behavioral:
• Brief Intervention #1
Brief online suggestion intended to increase the likelihood of quitting smoking that takes less than 1 minute to complete.
• Brief Intervention #2
Brief online suggestion intended to increase the likelihood of quitting smoking that takes less than 1 minute to complete.
• Brief Intervention #3
Brief online suggestion intended to increase the likelihood of quitting smoking that takes less than 7 minutes to complete.

Locations
Country Name City State
United States Palo Alto University i4Health Palo Alto California

Sponsors (1)
Lead Sponsor Collaborator
i4Health

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Percentage of participants who report quitting smoking Percentage of respondents who respond "no" to the question: "Have you smoked 1 or more cigarettes in the last 7 days?" 1 month No
Secondary Motivation to quit smoking Pre-post measure of motivation before and after the brief suggestions being tested are administered online. Specifically, response on a 0 to 10 scale (from "not at all" to "extremely") to the question "How motivated are you to stop smoking in the next 4 weeks?" 10 minutes No
See also
  Status Clinical Trial Phase
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Active, not recruiting NCT02643914 - Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings N/A
Recruiting NCT02422914 - Benefits of Tobacco Free Cigarette N/A
Active, not recruiting NCT02629679 - Sports, Education and Consumption of Substances in Adolescents N/A
Completed NCT02385227 - Characterization of Biomarkers of Tobacco Exposure, Urge-to-Smoke Following Exclusive and Dual Ad Lib Use of Electronic Cigarettes N/A
Completed NCT02218281 - Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation N/A
Completed NCT01199380 - Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms Phase 2
Completed NCT00802919 - Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors Phase 4
Completed NCT00756704 - The Effectiveness of Smoking Cessation Guidelines in the Emergency Department N/A
Completed NCT01081119 - Brief Voluntary Alcohol and Drug Intervention for Middle School Youth Phase 2
Completed NCT01692353 - Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers N/A
Completed NCT00682474 - School Nurse-Delivered Smoking Cessation Intervention Phase 2/Phase 3
Completed NCT05520775 - Semaglutide for Alcohol Use Disorder Phase 2
Terminated NCT03840694 - Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior N/A
Completed NCT06032793 - Effects of Deep Breathing Exercise on Pulmonary Function, Perceived Stress and Physical Fitness. N/A
Terminated NCT03326128 - High Dose Bupropion for Smoking Cessation - Pilot Study Phase 2
Recruiting NCT03218670 - Your Health in On Click N/A
Completed NCT02538042 - Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue) N/A
Completed NCT02792426 - Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users Phase 1

External Links